한글목차

바이오의약품 발효 시스템 시장 규모는 2025년 185억 5,000만 달러에서 2026-2034년 CAGR 6.43%로 성장하여 2034년에는 325억 달러에 이를 것으로 예측됩니다.

바이오의약품 발효 시스템 시장은 생물학적 제제 및 바이오의약품 제품에 대한 수요 증가를 배경으로 괄목할 만한 성장세를 보이고 있습니다. 헬스케어 산업이 보다 개인화되고 효과적인 치료법으로 전환함에 따라 백신, 단클론 항체 및 기타 생물학적 제제 생산에 있어 발효 시스템은 필수 불가결한 요소로 자리 잡고 있습니다. 바이오 제약 기업들이 수율, 효율성, 제품 품질을 향상시키는 첨단 발효 기술을 우선시함에 따라 시장 확대가 예상됩니다.

기술 혁신은 바이오 의약품 발효 시스템 시장을 크게 형성하고 있으며, 바이오 리액터 설계, 제어 시스템, 공정 최적화의 혁신이 생산 능력을 향상시키고 있습니다. 일회용 바이오리액터와 첨단 모니터링 기술의 개발은 유연성을 높이고, 오염 위험을 줄이며, 진화하는 바이오 의약품 제조의 요구에 대응하고 있습니다. 또한, 자동화와 데이터 분석의 통합으로 실시간 공정 모니터링 및 제어가 가능해져 시장 성장을 더욱 촉진하고 있습니다.

또한, 규제 준수와 품질 보증에 대한 관심이 높아지면서 바이오 의약품 발효 시스템 시장 시장 역학에 영향을 미치고 있습니다. 기업들은 점점 더 엄격한 규제 기준을 충족하고 제품 안전성을 높이는 솔루션을 찾고 있으며, 제조업체들은 일관된 품질과 추적성을 보장하는 시스템을 개발해야 하는 상황에 직면해 있습니다. 바이오 의약품 발효 시스템 시장 전망은 혁신, 품질, 규제 준수에 대한 노력으로 특징지어지며, 발효 시스템이 바이오 의약품 생산에서 중요한 구성 요소로 남을 수 있도록 보장합니다.

목차

제1장 서론

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 바이오의약품 발효 시스템 시장 : 제품 유형별

제5장 세계의 바이오의약품 발효 시스템 시장 : 용도별

제6장 세계의 바이오의약품 발효 시스템 시장 : 최종사용자별

제7장 세계의 바이오의약품 발효 시스템 시장 : 지역별

제8장 경쟁 구도

제9장 기업 개요

영문목차

The Biopharmaceutical Fermentation Systems Market size is expected to reach USD 32.50 Billion in 2034 from USD 18.55 Billion (2025) growing at a CAGR of 6.43% during 2026-2034.

The biopharmaceutical fermentation systems market is experiencing significant growth, driven by the increasing demand for biologics and biopharmaceutical products. As the healthcare industry shifts towards more personalized and effective treatments, fermentation systems are becoming essential for the production of vaccines, monoclonal antibodies, and other biologics. The market is expected to expand as biopharmaceutical companies prioritize advanced fermentation technologies that enhance yield, efficiency, and product quality.

Technological advancements are significantly shaping the biopharmaceutical fermentation systems market, with innovations in bioreactor design, control systems, and process optimization enhancing production capabilities. The development of single-use bioreactors and advanced monitoring technologies is improving flexibility and reducing contamination risks, catering to the evolving needs of biopharmaceutical manufacturing. Additionally, the integration of automation and data analytics is enabling real-time process monitoring and control, further driving market growth.

Furthermore, the growing emphasis on regulatory compliance and quality assurance is influencing the biopharmaceutical fermentation systems market dynamics. Companies are increasingly seeking solutions that meet stringent regulatory standards and enhance product safety, prompting manufacturers to develop systems that ensure consistent quality and traceability. The future of the biopharmaceutical fermentation systems market is characterized by a commitment to innovation, quality, and regulatory compliance, ensuring that fermentation systems remain critical components in the production of biopharmaceuticals.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Fermenters
• Bioreactors
• Consumables
• Others

By Application

• Antibiotics
• Recombinant Proteins
• Monoclonal Antibodies
• Others

By End-User

• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Merck KGaA, Danaher Corporation, Sartorius AG, GE Healthcare, Eppendorf AG, BioRad Laboratories Inc, Boehringer Ingelheim GmbH, Lonza Group AG, Fujifilm Diosynth Biotechnologies, Wuxi Biologics, Samsung Biologics, Pall Corporation, Corning Incorporated, Applikon Biotechnology BV

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEMS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Fermenters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Bioreactors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEMS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Antibiotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Recombinant Proteins Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Monoclonal Antibodies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEMS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEMS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEMS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Merck KGaA
  • 9.2.3 Danaher Corporation
  • 9.2.4 Sartorius AG
  • 9.2.5 GE Healthcare
  • 9.2.6 Eppendorf AG
  • 9.2.7 Bio-Rad Laboratories Inc
  • 9.2.8 Boehringer Ingelheim GmbH
  • 9.2.9 Lonza Group AG
  • 9.2.10 Fujifilm Diosynth Biotechnologies
  • 9.2.11 Wuxi Biologics
  • 9.2.12 Samsung Biologics
  • 9.2.13 Pall Corporation
  • 9.2.14 Corning Incorporated
  • 9.2.15 Applikon Biotechnology B.V